| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |